Various categories of cytokines participate in the control of feeding, including interleukin-1 and -6 and other activators of gp 130, leptin (ob protein), interleukin-8 and other chemokines, tumor necrosis factor-alpha, and interferon-alpha. These feedinginhibitory cytokines may play a role in the regulation of food intake during physiological (eg a role proposed for leptin) and pathophysiological (eg proinflammatory cytokines) conditions. Data show that various cytokines participate in acute and chronic disease-associated anorexia such as during infection, inflammation or malignancy. Food intake suppression (reported as anorexia) is also a common central manifestation observed during cytokine immunotherapy in humans. The concept of local production of various cytokines within specific brain regions in response to peripheral challenges and pathophysiological processes has broad implications for the interpretation of brain cytokines as mediators or participants in CNS modulation of feeding and anorexia.
Introduction
An integrative strategy that has combined neurological, behavioral, cellular, molecular and genetic approaches has been instrumental in the study of the control of feeding by cytokines. Overall, cytokines play critical roles in feeding during physiological and pathophysiological conditions. Multiple models and new concepts have been proposed involving leptin and=or proinflammatory cytokines. Selected concepts are briefly discussed in this review.
Anorexia during disease can be beneficial or deleterious depending on the timing and duration. 1 Temporary anorexia during acute disease may be beneficial to an organism since a restriction in the intake of micro-and macro-nutrients will inhibit bacterial growth. For instance, forced feeding during infection can increase morbidity and mortality. Long-term anorexia during chronic disease, however, is deleterious to an organism and may be associated with cachexia, which can ultimately result in death. Cachexia is characterized by a progressive wasting of adipose and muscle tissues accompanied by anorexia, malnutrition and body weight loss, asthenia and anemia. Cachexia is observed in chronic pathological processes including cancer, human immunodeficiency virus (HIV) infection, chronic bacterial and parasitic diseases, chronic inflammatory bowel disease, chronic liver disease, chronic obstructive pulmonary disease, chronic cardiovascular disease, and rheumatoid arthritis. 1 Other central manifestations frequently occurring during acute disease include fever and sleep changes. These manifestations, however, can be dissociated from anorexia. 1 For example, sodium salicylate and other antipyretics block fever induced by bacterial endotoxin but do not restore appetite. This is consistent with the clinical observation that patients receiving antipyretic therapy exhibit anorexia.
Local production of cytokines within discrete brain regions in response to pathophysiological conditions is involved in the suppression of feeding during disease
Proinflammatory cytokines are involved in the anorexia associated with cytokine immunotherapy and various disease conditions. 1 However, controversy has been generated that increased concentrations of anorexigenic cytokines in the circulation or other body fluids (eg cerebrospinal fluid) are required for their involvement in anorexia. Cytokines, nevertheless, act predominantly by paracrine, autocrine and intracrine manners, and these activities cannot be detected in the circulation. 2 Thus involvement of cytokines in the anorexia of immunotherapy or disease is not only associated with increased cytokine concentrations in the circulation, but also involves local synthesis in the brain. Animal models have provided compelling evidence for this concept. For instance, early anorexia in rats bearing prostate adenocarcinoma tumor cells is associated with an up-regulation of cytokines in brain regions during the period of early cancer anorexia. 3 In fact, brain cytokine production (eg interleukin-1 beta, tumor necrosis factor-alpha) in response to the peripheral tumor could be involved in the induction of neurological and neuropsychiatric manifestations or their exacerbation in rodent models of prostate cancer. Cytokine up-regulation in the hypothalamus is relevant to early cancer anorexia, while in the cerebral cortex and other brain regions, it could be involved in the induction of neuropsychiatric manifestations that commonly occur during cancer. 4 This important concept of local production of cytokines within the brain and cytokines as mediators of neurological and neuropsychiatric manifestations of disease has broad implications. Brain synthesis of cytokines has been demonstrated in response to peripheral models of cancer, inflammation, and during peripheral cytokine administration. The data obtained from tumor-bearing rodents show that paracrine interactions within the brain represent a predominant mode of cytokine action and result in brain cytokine production in response to peripheral tumor development. This model proposes that, through brain positive feedback systems, paracrine interactions can sustain local cytokine production independently of circulating cytokines. This model is also consistent with the cascade pattern associated with cytokine production and with the ability of brain cells (eg microglia, astrocytes, endothelial cells of the cerebrovasculature) to produce cytokines. 2 Neurological and psychiatric manifestations associated with cytokine immunotherapy for viral diseases, cancer or autoimmune processes (eg anorexia, fever, sleep changes, fatigue, neuroendocrine alterations) could also involve brain cytokine production and action. 4 
Cytokines modulate feeding by direct action in the brain
Cytokines that induce anorexia by central action include interleukin-1, long-chain helical cytokines that include the interleukin-6 subfamily and leptin (OB protein), interleukin-8 and other chemokines=intercrines, tumor necrosis factor-alpha, and interferon-alpha. 1 Immunomolecules upregulated by cytokines (eg platelet activating factor) can also induce anorexia by direct action in the brain. 2 Although peripheral and brain mechanisms may be involved in cytokine-induced anorexia, the net behavioral response results from signaling to a final pathway for eating=appetite control that depends on brain mechanisms. Cytokines can also modulate gastrointestinal activities (eg gastric motility and emptying) that can inhibit feeding; this can be a direct action in the gastrointestinal system, or can be mediated by the brain with efferent signaling via the autonomic nervous system outflow. Cytokines can also induce the release of hormones that modulate feeding (eg cholecystokinin, glucagon, insulin and leptin) and induce metabolic changes and alterations in intermediate metabolism which can also impact on feeding regulation. 1 Cytokines can interact with the nervous system in different ways (depending on the cytokine) including via transport from the peripheral circulation to the brain across the blood -brain barrier, via the circumventricular organs (which lack a blood -brain barrier), and through retrograde axonal cytokine transport, cytokine-induced generation of chemical mediators (eg prostaglandins and=or nitric oxide from cerebrovascular endothelium, meningeal macrophages and perivascular microglia), and periphery-to-brain communication via afferent neural fiber signalling. 5 Most of these models have not been established conclusively, such as the brain production of cytokines as well as direct CNS action of cytokines.
Cytokine action on brain mechanisms can be direct (via modulation of neuronal activity) or indirect (via modulation of brain chemistry)
The hypothalamic feeding-associated sites are targets for cytokine action. 2 Cytokines can act directly on neurons that are thought to participate in the control of feeding in the lateral hypothalamic area (LHA), the ventromedial nucleus (VMN), paraventricular nucleus (PVN) and arcuate nucleus (AN) of the hypothalamus. The neurophysiological effects induced by interleukin-1 beta, interferon-alpha and other cytokines involve modulation of various neuronal ionic conductances including sodium, potassium and calcium channel currents. 6 Direct cytokine (eg interleukin-1 beta) administration into the hypothalamic VMN induces robust anorexia. Both the behavioral effects and neurophysiological changes induced by cytokines can be blocked with the appropriate antagonists. 1 Cytokines act in a cascade pattern, that is a cytokine can induce the production and release of other cytokines, including within the CNS, 7 and cytokine -cytokine interactions induce anorexia with additive or synergistic activities. 8 Cytokine generation of mediators (eg prostaglandins, nitric oxide) and cytokine-peptide=neurotransmitter interactions are also pivotal. 9 Neuropeptide Y blocks cytokine-induced anorexia, and cytokines block neuropeptide Y-induced feeding, that is cytokine-neuropeptide Y interactions are antagonistic. 10, 11 The best characterized examples are the NPY-induced inhibition or blockage of anorexia induced by interleukin-1 beta, interferon-alpha, ciliary neurotrophic factor, and leptin. Endogenous cytokine-peptide interactions relevant to feeding control include reciprocal cytokine-leptin-neuropeptide Y-CRH-glucocorticoid interactions. For instance, proinflammatory cytokines including interleukin-1 beta and tumor necrosis factor-alpha induce the release of corticotropinreleasing hormone, a potent anorexigenic factor. Evidence is also accumulating on possible interactions among cytokines and other CNS neuropeptide regulators of feeding including cocaine-and amphetamine-regulated transcript, proopiomelanocortin-derived peptides, melanin-concentrating hormone, agouti-related protein, alpha-melanocyte stimulating hormone and hypocretins=orexins.
Interleukin-1 beta-induced anorexia is associated with down-regulation of hypothalamic VMN G-protein alphasubunit subclass O, an important transductional requirement for the modulation of normal feeding. 12 Receptors coupled to G-protein alpha O that respond to feeding-stimulatory signals include receptors for galanin, endogenous opioids and possibly neuropeptide Y. Interleukin-1 betainduced modulation of G-protein alpha O -an interface between convergence of multiple chemical signals and divergence to intracellular messengers -in CNS feedingassociated sites may be involved in cytokine inhibition of feeding and antagonism of neuropeptide Y action. The consequence of this cytokine action is broad considering the integrative neurochemical control of feeding.
Cytokine-neurotransmitter interactions are also reciprocal. 9 For instance, cytokines such as interleukin-1 beta stimulate the release of hypothalamic histamine, serotonin, norepinephrine and dopamine (neurotransmitters involved in the control of feeding), and histamine, serotonin and catecholamines can also affect cytokine-mediated activities. Furthermore, sympathetic nervous system activation and outflow can induce cytokine production from peripheral immune cells. 13 
Cytokine action on feeding involves specific changes of meal parameters
Administration of cytokines (during cytokine immunotherapy) can induce anorexia by producing early satiety, a phenomenon also frequently observed during progression of cancer. The early satiety phenomenon involves a reduction of meal size and duration, when patients report the motivation to initiate a meal, but the meal terminates early with a very small amount of food eaten.
Computerized behavioral monitoring of the microstructure of eating has reported that interleukin-1 beta (at doses that yield estimated pathophysiological concentrations in the cerebrospinal fluid) induces anorexia by reducing meal size and meal duration dose-dependently, 1 without affecting meal frequency. This behavioral mode of action is consistent with the neurophysiological pattern at estimated pathophysiological levels, that is, interleukin-1 beta-induced activation of feeding-regulatory glucose responsive neurons in the hypothalamic VMN (a site involved in the integrative control of meal termination) predicts changes of meal size and meal duration.
Other cytokines show similar profiles; for instance, interferon-alpha induces anorexia by reducing meal size and meal duration without affecting meal frequency, 1 while interleukin-8 1 and leptin 14 -16 reduce meal size exclusively. These precise changes in meal parameters suggest a specific action of interleukin-1 beta, interferon, interleukin-8 and leptin on CNS feeding-associated sites involved in the integrative regulation of satiety.
It should be noted that the effect of cytokine-induced profiles on the meal pattern can be different depending on the doses used and concentrations of the cytokine. For instance, suprapathophysiological=pharmacological= toxicological concentrations of interleukin-1 beta in response to exogenous dosing are associated with a nonspecific inhibition of multiple behaviors including decreased locomotor activity and a significant inhibition of meal parameters (decrease of meal size, meal duration and meal frequency). Cellular and molecular models (eg, electrophysiological) also show that the cytokine response profile can change depending on the concentrations used. Overall, behavioral, cellular and molecular models demonstrate that cytokines can induce nonspecific activities when used at high concentrations. Thus, caution is essential when interpreting data obtained with high doses or concentrations of a cytokine.
Interactions among proinflammatory (stimulatory, anorexigenic) cytokines can be synergistic to induce anorexia Brain cytokines interact to induce anorexia. Various key interactions which involve proinflammatory cytokines (eg among interleukin-1 beta, interleukin-8 and tumor necrosis factor-alpha) exhibit synergistic activities. 8 That is, the anorectic response to cytokine combinations is larger than the sum of the individual effects. One mechanism for this synergism is the convergence of different signaling pathways onto common downstream mediators, eg interleukin-1 and tumor necrosis factor-alpha modulation of NF-kB-inducing kinase, a MAP3K related kinase. One note of interest is the proposal that leptin can also act as a proinflammatory cytokine under certain conditions. Brain cytokines also induce the production of other cytokines. For instance, interleukin-1 beta up-regulates multiple cytokine components (ligands, receptors, transducing molecules) in discrete brain regions during interleukin-1 betainduced anorexia. 17 Interleukin-1 beta also induces its own production and synthesis of its receptors and transducing molecules.
The ratio between proinflammatory (stimulatory, anorexigenic) and antiinflammatory (immunoinhibitory) cytokines is associated with the magnitude of feeding inhibition The brain ratio between proinflammatory (eg interleukin-1 beta, tumor necrosis factor-alpha) and antiinflammatory (eg interleukin-1 receptor antagonist, interleukin-4, interleukin-10, transforming growth factor-beta 1) cytokines is relevant to the magnitude of anorexia in pathophysiological and experimental conditions. That is, an increased proinflammatory=antiinflammatory cytokine ratio can be associated with a greater magnitude of neurological and neuropsychiatric manifestations. This is because a CNS dysregulation in cytokine balance could result in deleterious amplification cycles of cellular activation and cytotoxicity. Data obtained with bacterial product challenges are compelling. For instance, bacterial lipopolysaccharide is significantly more potent than muramyl dipeptide (MDP) in inducing anorexia and in up-regulating proinflammatory cytokine (such as interleukin-1 and tumor necrosis factor-alpha) components in brain regions, while MDP is more potent in up-regulating antiinflammatory cytokine (eg interleukin-1 receptor antagonist and transforming growth factor-beta 1) components. 18 These results support the notion that the magnitude of anorexia induced by bacterial products may involve the ratio between stimulatory and inhibitory cytokines. 7 Another issue that merits attention is that cytokine balance can be considered of comprising at least two components, the first within a cytokine system (eg interleukin-1 and interleukin-1 receptor antagonist), and the second among different cytokine systems (eg inhibitory cytokines downregulating the activities of proinflammatory cytokines). 17 An additional line of evidence has been provided by data from transgenic models. 5 Animals which overexpress proinflammatory cytokines display an exaggerated inflammatory response. The overexpression of a single cytokine can have repercussions on multiple cytokine systems, leading to neurological and pathophysiological consequences that are beyond those of the single cytokine. On the other hand, antiinflammatory cytokine knockouts, such as interleukin-10 or transforming growth factor-beta 1 knockouts, show poor survival prognosis. Transgenic models support the same notion, that is, interleukin-1 receptor antagonist transgenic mice show resistance to the lethal effects of bacterial lipopolysaccharide.
Conclusion
Overall, it is important to consider the potential interrelationships among cytokines, peptides=neuropeptides and neurotransmitters, and modifications of signal transduction and intracellular mediator events in the CNS in the induction and maintenance of anorexia. 9 Various cytokines including interleukin-1 beta and tumor necrosis factoralpha up-regulate leptin and gp 130 molecules, and interestingly, specific cytokine mechanisms (eg gp 130 and related molecules and=or downstream signals such as the JAK-STAT pathway) may be an interface for feeding control in health (through leptin, a putative physiological satiety factor, longterm regulator of body adiposity as well as proinflammatory cytokine) and disease (through multiple interleukin-6 subfamily members that include ciliary neurotrophic factor). 19 Also, suppressors-of-cytokine-signaling (SOCS) protein family members have been identified in peripheral organs and brain (eg hypothalamus) and these factors are also modulated by cytokines including leptin. Multiple reciprocal, parallel and sequential cytokine -cytokine interactions and cytokine -neuropeptide -neurotransmitter -hormone interactions occur. Of interest are also the data on brain administration of interleukin-1 receptor antagonist which inhibits the suppression of food intake caused by central or peripheral administration of leptin, and data obtained from interleukin-1 signaling receptor knockout mice which show no reduction of food intake in response to leptin. 20 Based on these observations, the authors propose that leptin actions in the brain may depend on interleukin-1. 20 Overall, because of the multiple interrelationships, caution is essential when interpreting data obtained with individual cytokines.
